A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
The Florida sun is brutal, and while slathering on sunscreen feels like a no-brainer, this summer the rules have changed.
June 2026 - Clinical Trial and Case Study Results Highlight Diagnostic and Therapeutic Potential of SAR-bisPSMA Portfolio.
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...
Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...
Symptoms such as a weak urine stream or frequent trips to the bathroom are common among middle-aged and older men. Many ...
In the next episode of NDTV Lifeline, we dive deep into why men's health matters and how silence is the most dangerous ...
A next-generation blood test could improve early detection of the most dangerous forms of prostate cancer. "The major ...
The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results